PL3402811T3 - Analogi egf(a) z podstawnikami kwasu tłuszczowego - Google Patents
Analogi egf(a) z podstawnikami kwasu tłuszczowegoInfo
- Publication number
- PL3402811T3 PL3402811T3 PL17701078T PL17701078T PL3402811T3 PL 3402811 T3 PL3402811 T3 PL 3402811T3 PL 17701078 T PL17701078 T PL 17701078T PL 17701078 T PL17701078 T PL 17701078T PL 3402811 T3 PL3402811 T3 PL 3402811T3
- Authority
- PL
- Poland
- Prior art keywords
- egf
- analogues
- fatty acid
- acid substituents
- substituents
- Prior art date
Links
- 125000005313 fatty acid group Chemical group 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2016070791 | 2016-01-13 | ||
CN2016076580 | 2016-03-17 | ||
EP16195965 | 2016-10-27 | ||
EP17701078.2A EP3402811B1 (en) | 2016-01-13 | 2017-01-13 | Egf(a) analogues with fatty acid substituents |
PCT/EP2017/050668 WO2017121850A1 (en) | 2016-01-13 | 2017-01-13 | Egf(a) analogues with fatty acid substituents |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3402811T3 true PL3402811T3 (pl) | 2022-07-11 |
Family
ID=57868232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL17701078T PL3402811T3 (pl) | 2016-01-13 | 2017-01-13 | Analogi egf(a) z podstawnikami kwasu tłuszczowego |
Country Status (26)
Country | Link |
---|---|
US (2) | US10822385B2 (pl) |
EP (1) | EP3402811B1 (pl) |
JP (2) | JP6797926B2 (pl) |
KR (1) | KR102417487B1 (pl) |
CN (1) | CN108473550B (pl) |
AU (1) | AU2017207862B2 (pl) |
BR (1) | BR112018013820A2 (pl) |
CA (1) | CA3010756A1 (pl) |
CL (1) | CL2018001868A1 (pl) |
CO (1) | CO2018007440A2 (pl) |
DK (1) | DK3402811T3 (pl) |
ES (1) | ES2916998T3 (pl) |
HR (1) | HRP20220720T1 (pl) |
HU (1) | HUE058647T2 (pl) |
IL (1) | IL260043A (pl) |
LT (1) | LT3402811T (pl) |
MX (1) | MX2018008681A (pl) |
MY (1) | MY195199A (pl) |
PE (1) | PE20181376A1 (pl) |
PH (1) | PH12018501502A1 (pl) |
PL (1) | PL3402811T3 (pl) |
RS (1) | RS63298B1 (pl) |
RU (1) | RU2747877C2 (pl) |
SA (1) | SA518391996B1 (pl) |
SI (1) | SI3402811T1 (pl) |
WO (1) | WO2017121850A1 (pl) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE049813T2 (hu) | 2016-01-13 | 2020-10-28 | Gruenenthal Gmbh | 3-((hetero-)aril)-alkil-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-dekán származékok |
DK3402811T3 (da) | 2016-01-13 | 2022-06-13 | Novo Nordisk As | Egf(a)-analoger med fedtsyresubstituenter |
CA3011182A1 (en) | 2016-01-13 | 2017-07-20 | Grunenthal Gmbh | 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives |
EA034904B1 (ru) | 2016-01-13 | 2020-04-03 | Грюненталь Гмбх | Производные 3-(карбоксиметил)-8-амино-2-оксо-1,3-диазаспиро-[4.5]-декана |
WO2017121647A1 (en) | 2016-01-13 | 2017-07-20 | Grünenthal GmbH | 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives |
CA3068956A1 (en) | 2017-07-19 | 2019-01-24 | Novo Nordisk A/S | Bifunctional compounds |
MA49617A (fr) * | 2017-07-19 | 2020-05-27 | Novo Nordisk As | Analogues d'egf(a), préparation, formulations et utilisations associées |
WO2019023295A1 (en) * | 2017-07-27 | 2019-01-31 | Saint Louis University | HUMAN EPIDERMAL GROWTH FACTOR MODIFIED BY FATTY ACID |
AR116605A1 (es) | 2018-10-05 | 2021-05-26 | Novo Nordisk As | Compuestos bifuncionales que comprenden péptidos de insulina y péptidos de egf(a) |
CA3131997A1 (en) | 2019-03-22 | 2020-10-01 | 3M Innovative Properties Company | Fall-protection system with monitoring system |
CN110357969B (zh) * | 2019-05-27 | 2022-03-08 | 北京志道生物科技有限公司 | 一种GLP1-EGFa异源二聚体蛋白、功能及方法 |
US20220323544A1 (en) | 2019-08-07 | 2022-10-13 | Novo Nordisk A/S | Solid compositions comprising an egf(a) derivative and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid |
IL291893A (en) | 2019-11-07 | 2022-06-01 | Novo Nordisk As | Solid preparations comprising a pcsk9 inhibitor and a salt of n-(8-(2-hydroxybenzoyl)amino) caprylic acid |
WO2023012263A1 (en) | 2021-08-04 | 2023-02-09 | Novo Nordisk A/S | Solid oral peptide formulations |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1909823A2 (en) | 2005-07-29 | 2008-04-16 | Amprotein Corporation | Chimeric therapeutic agents |
EP2330124B1 (en) | 2005-08-11 | 2015-02-25 | Amylin Pharmaceuticals, LLC | Hybrid polypeptides with selectable properties |
JP5721432B2 (ja) | 2007-08-15 | 2015-05-20 | ノボ・ノルデイスク・エー/エス | アミノ酸含有アルキレングリコール反復単位を含むアシル部を有するインスリン |
MX2010011499A (es) | 2008-04-23 | 2010-11-12 | Amgen Inc | Variantes de proproteina neutralizante de convertasa subtilisina kexina de tipo 9 (pcsk9) y sus usos. |
WO2009143633A1 (en) | 2008-05-30 | 2009-12-03 | Institut De Recherches Cliniques De Montreal | Pcsk9 inhibitors and methods of use thereof |
TWI516501B (zh) | 2008-09-12 | 2016-01-11 | 禮納特神經系統科學公司 | Pcsk9拮抗劑類 |
CN101993485B (zh) | 2009-08-20 | 2013-04-17 | 重庆富进生物医药有限公司 | 促胰岛素分泌肽类似物同源二聚体及其用途 |
JPWO2012017774A1 (ja) * | 2010-08-02 | 2013-10-03 | 日本電気株式会社 | 偏光子及び発光装置 |
CN102153652A (zh) | 2010-12-10 | 2011-08-17 | 浙江大学 | 一种融合蛋白的表达方法及用途 |
WO2012110422A1 (en) | 2011-02-15 | 2012-08-23 | Novo Nordisk A/S | Long-acting il-1 receptor antagonists |
JP2014519848A (ja) * | 2011-06-20 | 2014-08-21 | ジェネンテック, インコーポレイテッド | Pcsk9結合ポリペプチドと使用方法 |
TWI596110B (zh) * | 2011-09-23 | 2017-08-21 | 諾佛 儂迪克股份有限公司 | 新穎升糖素類似物 |
UY34347A (es) | 2011-09-26 | 2013-04-30 | Novartis Ag | Proteínas de función dual para tratar trastornos metabólicos |
US20140357838A1 (en) * | 2011-12-21 | 2014-12-04 | Novo Nordisk A/S | N-Terminally Modified Insulin Derivatives |
CN112142855A (zh) | 2012-05-18 | 2020-12-29 | 爱德迪安(北京)生物技术有限公司 | 用于糖尿病治疗的蛋白、蛋白缀合物及其应用 |
AR092076A1 (es) | 2012-08-22 | 2015-03-18 | Lilly Co Eli | Proteinas homodimericas |
CN104736558A (zh) | 2012-09-07 | 2015-06-24 | 赛诺菲 | 用于治疗代谢综合征的融合蛋白 |
AU2014255608B2 (en) * | 2013-04-18 | 2018-01-25 | Novo Nordisk A/S | Stable, protracted GLP-1/glucagon receptor co-agonists for medical use |
SG11201602503TA (en) | 2013-10-03 | 2016-04-28 | Moderna Therapeutics Inc | Polynucleotides encoding low density lipoprotein receptor |
CA2935285A1 (en) | 2014-02-21 | 2015-08-27 | Medimmune, Llc | Anti-pcsk9-glp-1 fusions and methods for use |
CN106536547A (zh) * | 2014-06-04 | 2017-03-22 | 诺和诺德股份有限公司 | 用于医疗用途的glp‑1/胰高血糖素受体共激动剂 |
CN104558198A (zh) | 2014-07-25 | 2015-04-29 | 成都贝爱特生物科技有限公司 | GLP-1类似物和amylin类似物的融合蛋白制备及其用途 |
CA2979617C (en) * | 2015-03-19 | 2024-01-02 | Institut De Cardiologie De Montreal | Grp94 derived polypeptides for inhibiting pcsk9 and methods of use |
CN105367884A (zh) | 2015-11-02 | 2016-03-02 | 陈薇 | 一种绝缘耐火抗辐射的屏蔽电缆材料及其制备方法 |
DK3402811T3 (da) | 2016-01-13 | 2022-06-13 | Novo Nordisk As | Egf(a)-analoger med fedtsyresubstituenter |
MA49617A (fr) | 2017-07-19 | 2020-05-27 | Novo Nordisk As | Analogues d'egf(a), préparation, formulations et utilisations associées |
CA3068956A1 (en) | 2017-07-19 | 2019-01-24 | Novo Nordisk A/S | Bifunctional compounds |
-
2017
- 2017-01-13 DK DK17701078.2T patent/DK3402811T3/da active
- 2017-01-13 HR HRP20220720TT patent/HRP20220720T1/hr unknown
- 2017-01-13 JP JP2018536444A patent/JP6797926B2/ja active Active
- 2017-01-13 HU HUE17701078A patent/HUE058647T2/hu unknown
- 2017-01-13 PL PL17701078T patent/PL3402811T3/pl unknown
- 2017-01-13 EP EP17701078.2A patent/EP3402811B1/en active Active
- 2017-01-13 CN CN201780006783.6A patent/CN108473550B/zh active Active
- 2017-01-13 BR BR112018013820-7A patent/BR112018013820A2/pt not_active Application Discontinuation
- 2017-01-13 KR KR1020187022105A patent/KR102417487B1/ko active IP Right Grant
- 2017-01-13 AU AU2017207862A patent/AU2017207862B2/en not_active Ceased
- 2017-01-13 PE PE2018001257A patent/PE20181376A1/es unknown
- 2017-01-13 CA CA3010756A patent/CA3010756A1/en not_active Withdrawn
- 2017-01-13 US US16/069,932 patent/US10822385B2/en active Active
- 2017-01-13 ES ES17701078T patent/ES2916998T3/es active Active
- 2017-01-13 MY MYPI2018702319A patent/MY195199A/en unknown
- 2017-01-13 LT LTEPPCT/EP2017/050668T patent/LT3402811T/lt unknown
- 2017-01-13 RU RU2018127882A patent/RU2747877C2/ru active
- 2017-01-13 SI SI201731149T patent/SI3402811T1/sl unknown
- 2017-01-13 RS RS20220538A patent/RS63298B1/sr unknown
- 2017-01-13 MX MX2018008681A patent/MX2018008681A/es unknown
- 2017-01-13 WO PCT/EP2017/050668 patent/WO2017121850A1/en active Application Filing
-
2018
- 2018-06-14 IL IL260043A patent/IL260043A/en unknown
- 2018-07-09 CL CL2018001868A patent/CL2018001868A1/es unknown
- 2018-07-10 SA SA518391996A patent/SA518391996B1/ar unknown
- 2018-07-12 PH PH12018501502A patent/PH12018501502A1/en unknown
- 2018-07-16 CO CONC2018/0007440A patent/CO2018007440A2/es unknown
-
2020
- 2020-09-17 US US17/024,264 patent/US20200407409A1/en not_active Abandoned
- 2020-11-17 JP JP2020190846A patent/JP2021035989A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL260043A (en) | egf(a) analogues with fatty acid converters | |
ZA201805705B (en) | Pth prodrugs | |
IL265588A (en) | Treprostinil prodrugs | |
IL248632B (en) | micellar nanocomplex | |
GB2595424B (en) | A connector arrangement | |
EP2902708A4 (en) | GAS TURBINE BURNING CHAMBER FOR SEVERAL FUELS | |
GB2533030B (en) | A shroud assembly | |
GB2549510B (en) | A Connector | |
GB201611674D0 (en) | A turbine arrangement | |
GB201518766D0 (en) | A head up display | |
GB201419661D0 (en) | Duct assembly with a connector | |
GB2539972B (en) | A connector | |
SG11201608342VA (en) | Omega-3 analogues | |
PL3280879T3 (pl) | Układ do turbiny | |
HK1217152A2 (zh) | 種新型導風口結構 | |
GB201518909D0 (en) | A formulation | |
PT3402811T (pt) | Análogos de egf(a) com substituintes de ácidos gordos | |
AU201615213S (en) | A head board | |
LT3100836T (lt) | Plokštės gamyba | |
GB2542153B (en) | A connector | |
GB201513331D0 (en) | A Banner Assembly | |
GB201507081D0 (en) | Nozzle tip manufacturing | |
EP3658527A4 (en) | ACRYLIC ACID ANALOGUES | |
GB201521110D0 (en) | Beyond MK4 A | |
GB201612570D0 (en) | A turbine |